Table 4.
Odds ratios (95% CI) and ROC analysis for the association between each component of MetS and markers.
| Adiponectin (Q4 versus Q1) | HOMA-IR (Q4 versus Q1) | A/H ratio (Q4 versus Q1) | ||||
|---|---|---|---|---|---|---|
| OR∗ (95% CI) | AUC (SE) | OR∗ (95% CI) | AUC (SE) | OR∗ (95% CI) | AUC (SE) | |
| Abdominal obesity | 0.37 (0.27–0.51) | 0.58 (0.01) | 2.74 (2.01–3.72) | 0.61 (0.01) | 0.20 (0.13–0.31) | 0.63 (0.01) |
| High triglycerides | 0.42 (0.28–0.65) | 0.64 (0.02) | 4.35 (2.82–6.71) | 0.67 (0.02) | 0.20 (0.13–0.31) | 0.69 (0.02) |
| High blood pressure | 0.33 (0.24–0.46) | 0.61 (0.01) | 1.55 (1.14–2.10) | 0.55 (0.01) | 0.44 (0.33–0.59) | 0.61 (0.01) |
| Low HDL | 0.71 (0.51–0.99) | 0.51 (0.02) | 1.74 (1.25–2.42) | 0.57 (0.02) | 0.50 (0.36–0.69) | 0.55 (0.02) |
| Abnormal glucose | 0.42 (0.28–0.63) | 0.63 (0.02) | 10.08 (6.32–16.06) | 0.75 (0.02) | 0.14 (0.09–0.23) | 0.73 (0.02) |
CI, confidence interval; AUC, area under the curve; SE, standard error; A/H ratio, adiponectin to homeostasis assessment-insulin resistance; MetS, metabolic syndrome; Q4, highest quartile; Q1, lowest quartile.
∗Adjusted for sex, age, smoking status, and LDL cholesterol.